Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in theme_biblio_custom() (line 367 of /home/phcogcommn/

Chromatography Assisted Validation of Alternate Plant Materials in a Polyherbal Formulation: A Prospective Positive Substitution


Pharmacognosy Communications,2021,11,2,127-132.
Published:April 2021
Type:Original Article

Chromatography Assisted Validation of Alternate Plant Materials in a Polyherbal Formulation: A Prospective Positive Substitution

Sunita Shailajan1,*, Swati Singh1, Sasikumar Menon2

1Herbal Research Lab (Industrial Co-ordination Centre), Ramnarain Ruia Autonomous College, Matunga, Mumbai, Maharashtra, INDIA.

2Therapeutic Drug Monitoring Laboratory, Sion (East), Mumbai, Maharashtra, INDIA.


Introduction: Bergenia ligulata Wall. is a popular medicinal herb from family Saxifragaceae, belonging to category of medicinal plants, the authentic species of which are not available easily. Though Ayurvedic Formulary of India prescribes the use of Bergenia ligulata, manufacturers have been using different species of Bergenia in many traditional Ayurvedic formulations including Pushyanuga churna (PC). Commercial exploitation of Bergenia ligulata has resulted in imbalance between supplies of this plant drug as compared to its demand. Commercially therefore, Bergenia ciliata which is more abundantly available, is substituted for Bergenia ligulata. Methods: The present study was undertaken to validate the use of Bergenia ciliata in a polyherbal formulation (PC), as a positive substitute for Bergenia ligulata. One in-house PC containing B. ligulata, along with two commercially available formulations of PC containing different species of Bergenia were compared for their bergenin content using validated HPLCmethod to evaluate the phytochemical equivalence. Results: Bergenin content in the in-house formulation containing B. ligulata was found to be 0.27mg/gm whereas the commercial samples containing B. ciliata contained 0.24mg/gm of bergenin while another marketed formulation without label claim contained 0.162mg/gm of bergenin. The results clearly support the use of B. ciliata as a positive substitute for B. ligulata in PC. Conclusion: Positive substitution can be adopted by manufacturing units for the medicinal plant ingredients, which are scarcely available, to prevent their over-exploitation from the wild. Such substitutions can be justified if phytochemical equivalence could be demonstrated by validated chromatographic techniques. Nevertheless, evidence based efficacy studies need to be conducted additionally to corroborate such usage.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.